is tirzepatide on the market yet for Weight Loss FDA Says Compounded Tirzepatide Must

Several other conditions, including a history of pancreatitis, gallbladder disease, severe gastroparesis, severe kidney disease, diabetic retinopathy, and a history of an eating disorder, need extra clinical caution rather than being automatic exclusions

Finally, common biochemical markers used for the diagnosis of acute pancreatitis in clinical practice include serum amylase and lipase.50 Some authors have reported that asymptomatic elevations of these biomarkers could be observed after administering GLP-1RAs.51,52 This subclinical phenomenon is not necessarily associated with a clinical pancreatic event

So youll just have to plan both accordingly

Renehan AG, Zwahlen M, Minder C, ODwyer ST, Shalet SM, Egger M

One of the first things many experience is a gradual reduction in appetite